By 1970 the administration of aluminium hydroxide and/or calcium carbonate as phosphate binders in dialysis patients was virtually universal practice. In 1972, Alfrey was one of the first to ...
To evaluate the efficacy of calcium carbonate as an alternative phosphate binder, we studied 20 patients maintained on dialysis during three consecutive periods. In period 1, the patients took ...
The FDA has started a review of Unicycive Therapeutics' drug for hyperphosphataemia in patients with chronic kidney disease ...
on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy. XPHOZAH offers a different mechanism ...
on dialysis as add-on therapy in patients who have inadequate response to phosphate binders or who are intolerant of any dose ...
on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy. Eighty percent of patients with CKD on ...
There is a dire need for innovative therapies like XPHOZAH for dialysis patients. For almost 50 years, binders have been the only prescription therapy available to lower phosphorus levels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback